��������

Dr. Alyssa Panitch, PhD: Founding Scientist. Dr. Panitch is the Leslie A. Geddes Professor of Biomedical Engineering in the Weldon School of Biomedical Engineering and the Vice Provost for Faculty Affairs at Purdue University. In addition, she serves as the Director of Deliberate Innovation for Faculty in Life Sciences and Medical Technologies in the Burton D. Morgan Center for Entrepreneurship at Purdue. Dr. Panitch has been federally funded since 2002 including NIH, NSF, and DOD funding. She has over 75 publications in peer-reviewed journals and over 60 invited talks based on her work. She is on the editorial advisory board for Biomacromolecules and for Biomatter, is an associate editor for Cellular and Molecular Bioengineering, and is a past regular member of the Biomaterials and Biointerfaces Study Section. She was the founder and CSO of a start-up company, AzERx (Arizona Engineered Therapeutics). AzERx completed a Phase I and Phase II STTR that advanced the Company to acquisition by Orthologic, Inc in 2006 in a deal then valued at $7M (currently “Capstone Therapeutics”). Dr. Panitch is a founder and scientific advisory board member of Symic Biomedical, Inc. a venture-funded company commercializing a platform technology developed in the Panitch laboratory. She co-founded Moerae Matrix, Inc., on technology developed in her laboratory at Purdue University. Dr. Panitch received her BS from Smith College in biochemistry, BA and PhD from U Mass Amherst in chemical engineering and polymer science, and did post-doctoral work in biomedical engineering at the University of Zurich.